The bill amends section 766.101 of the Florida Statutes, which pertains to medical malpractice review committees. It revises the definition of "medical review committee" to include additional entities, such as a managing entity as defined in s. 394.9082(2), and clarifies the roles of various committees involved in health care quality assurance. The bill also updates the language regarding the immunity from liability for these committees, ensuring that their investigations and records are not subject to discovery or admissible as evidence in civil or administrative actions against health care providers or managing entities.

Additionally, the bill specifies that individuals who attend committee meetings are not required to testify about the proceedings, findings, or recommendations of the committee, while still allowing for the use of information from original sources. The effective date for this act is set for July 1, 2025.